-
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging
Meijer, D., van Leeuwen, P. J., Donswijk, M. L., Boellaard, T. N., Schoots, I. G., van der Poel, H. G., Hendrikse, H. N., Oprea-Lager, D. E. & Vis, A. N., Jan 2022, In: BJU international. 129, 1, p. 54-62 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study: a multicenter retrospective study
Meijer, D., van Leeuwen, P. J., Oosterholt, P. M. J., Bodar, Y. J. L., van der Poel, H. G., Hendrikse, N. H., Donswijk, M. L., Wondergem, M., Vellekoop, A. E., van Moorselaar, R. J. A., Nieuwenhuijzen, J. A., Oprea-Lager, D. E. & Vis, A. N., Aug 2021, In: European journal of nuclear medicine and molecular imaging. 48, 9, p. 2960-2969 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible? Is Prediction of the Optimal Timing of Salvage Therapy Feasible?
Luiting, H. B., Remmers, S., Meijer, D., Vis, A. N., Donswijk, M., Oprea-Lager, D. E., Emmett, L., Rauscher, I., van der Poel, H. G., Roobol, M. J. & van Leeuwen, P. J., 1 Jun 2021, In: European Urology Open Science. 28, p. 47-51 5 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
